Microorganisms such as bacteria and viruses have repeatedly demonstrated an extraordinary ability to adapt and survive—often outpacing human innovation. History reminds us that almost every time a new antibiotic is introduced, bacteria eventually develop mechanisms to resist it. With a limited pipeline of new antibiotics and growing resistance, the challenge of treating infections is becoming increasingly complex.
In many parts of our country, selecting an effective antibiotic is further complicated by inconsistent and often inadequate laboratory support. In such settings, a strong understanding of the most common disease-causing organisms and their local antibiotic susceptibility patterns becomes essential. The choice of antimicrobial therapy must therefore be made with careful consideration—not only to ensure effectiveness but also to minimize side effects and slow the development of resistance.
Under ideal circumstances, antibiotics should be used strictly when there is clear evidence of a bacterial infection. Every effort must be made to confirm the diagnosis through appropriate investigations, including culture and sensitivity testing. Once results are available, the treatment should be refined to the narrowest spectrum antibiotic that is effective against the identified organism. Indiscriminate or unnecessary use of antibiotics can destroy beneficial bacteria and promote the growth of resistant strains, accelerating the problem of antimicrobial resistance.
In clinical practice, however, antibiotics are often initiated before a specific pathogen is identified—this is known as empirical therapy. In such cases, the choice of antibiotic should be guided by the most likely pathogens for the infection site, local resistance patterns, and patient-specific factors such as age. Knowledge of age-specific and site-specific organisms is therefore critical for making informed decisions.
Antibiotic prophylaxis also has a defined role in preventing infections in high-risk individuals. However, its use must strictly adhere to established guidelines to avoid misuse and unintended consequences.
The rational use of antibiotics is no longer optional—it is an urgent necessity. Without decisive action, we risk entering an era where common infections become untreatable due to widespread resistance. This responsibility extends beyond human health. Antibiotics must also be used judiciously in animals, and safeguards must be in place to prevent environmental contamination.
Ultimately, we are all part of an interconnected ecosystem—human, animal, and environmental health are inseparably linked. Embracing this “One Health” approach is critical if we are to preserve the effectiveness of antibiotics for future generations.
